Centrul Medical Medicover Victoria

Bucharest 10626

0 studies enrolling now · 2 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Severe Hypertriglyceridemia

Studies at this site

• Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) — Running, not enrolling
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed